BRAF and lung cancer: Genetic mutations in Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), epidermal growth factor receptor (EGFR), B-RAF (BRAF), and phosphatidylinositol 3-kinase (PI3K) signaling oncogenic pathways have been identified in lung cancer.